Oryzon Genomics S.A.

ORYZF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$5,619$12,257$21,317$28,725
Short-Term Investments$0$0$0$0
Receivables$1,384$2,013$1,004$1,294
Inventory$3$6$10$104
Other Curr. Assets$1,742$0$2,834$2,483
Total Curr. Assets$8,748$14,276$25,165$32,606
Property Plant & Equip (Net)$356$481$611$682
Goodwill$0$0$0$0
Intangibles$97,096$381$75,843$60,254
Long-Term Investments$0$0$0$0
Tax Assets$2,390$2,222$2,050$1,812
Other NC Assets$127$89,540$31$29
Total NC Assets$99,969$92,624$78,535$62,778
Other Assets$0$0$0$0
Total Assets$108,716$106,900$103,700$95,384
Liabilities
Payables$2,126$3,415$5,065$2,910
Short-Term Debt$7,947$10,237$10,380$3,424
Tax Payable$223$204$209$212
Deferred Revenue$0$0$0$0
Other Curr. Liab.$1,443$2,559$3,078$2,126
Total Curr. Liab.$11,739$16,414$18,732$8,672
LT Debt$3,256$3,451$7,061$10,347
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$2,390$2,222$2,050$1,812
Other NC Liab.$4,289$3,039$3,285$3,292
Total NC Liab.$9,935$8,711$12,396$15,451
Other Liabilities$0$0$0$0
Cap. Leases$57$79$99$0
Total Liabilities$21,674$25,125$31,128$24,122
Equity
Pref Stock$0$0$0$0
Common Stock$3,289$3,056$2,778$2,653
Retained Earnings-$19,336-$15,671-$12,318-$8,087
AOCI$0$0$0$0
Other Equity$103,090$94,390$82,112$76,695
Total Equity$87,042$81,775$72,572$71,262
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$108,716$106,900$103,700$95,384
Net Debt$5,585$1,430-$3,876-$14,954